Maridebart Cafraglutide (MariTide) — ≥99% Research Peptide

Monthly-Dosed GIP-Antagonist / GLP-1-Agonist Conjugate

Amgen's investigational peptide-antibody conjugate that pairs GLP-1 agonism with GIP receptor antagonism for sustained, once-monthly metabolic signaling.

Research Applications & Benefits

Product Specifications

Compound
Maridebart Cafraglutide (MariTide)
CAS Number
2762747-50-2
Molecular Weight
~6800 g/mol
HPLC Purity
≥99% (independently verified by CertikLabs)
Category
GLP-1 & Metabolic
Starting Price
$329.00 USD
Country of Origin
United States
Shipping
Cold-chain insulated packaging, fast domestic delivery
Payment
Card, ACH, and cryptocurrency (10% discount)

Quality & Verification

Every Maridebart Cafraglutide (MariTide) batch sold by PeptidesDirect is independently tested for purity (HPLC), identity (LC-MS), and concentration. A batch-specific Certificate of Analysis is available on request and anchored to a CertikLabs verification record for public inspection.

Frequently Asked Questions

Is Maridebart Cafraglutide (MariTide) suitable for human consumption?

No. Maridebart Cafraglutide (MariTide) is sold strictly for in-vitro laboratory research. It is not a drug, supplement, cosmetic, or food product and must not be administered to humans or animals.

What purity is Maridebart Cafraglutide (MariTide)?

Maridebart Cafraglutide (MariTide) ships at ≥99% verified by reverse-phase HPLC with mass-spec identity confirmation on every batch.

How is Maridebart Cafraglutide (MariTide) shipped and stored?

Vials are shipped lyophilized in temperature-controlled packaging. Store unopened lyophilized peptide at −20°C; once reconstituted with bacteriostatic water, store at 2–8°C and use within 28 days.

Research Use Only. This product is intended for licensed laboratory research and is not for human or veterinary use.